Assessment of Resmetirom Efficacy (80 mg vs. 100 mg) Stratified by Baseline Body Mass Index and Weight in Patients From the MAESTRO-NASH Trial

Gastroenterol Hepatol (N Y). 2024 Dec;20(12 Suppl 11):12-13.
No abstract available